Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MyoTherix

MyoTherix
2013 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$8.43M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of innovative therapeutics intended to be used for the treatment of muscle disorders. The company's therapeutics utilize an innovative and novel approach to target both cardiac and skeletal muscle weakness, enabling targeted patients to avail disease-modifying drugs and therapies.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 29540 Kohoutek Way
  • Union City, CA 94587
  • United States

+1 (857) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore MyoTherix’s full profile, request a free trial.

MyoTherix Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 27-Feb-2017 $8.43M 00.00 Completed Generating Revenue
1. Early Stage VC (Series A) 08-Jul-2015 000 000 000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

MyoTherix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00 00 00 00 00 00.00
To view this company’s complete Cap Table, request access »

MyoTherix Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
CureDuchenne Ventures Corporate Venture Capital Minority 000 0000 000000 0

MyoTherix Executive Team (4)

Name Title Board
Seat
Contact
Info
Michael Kelly Ph.D Chief Executive Officer, Director & Co-Founder
John Kincaid Co-Founder, President & Board Member
Mark De Souza Ph.D Co-Founder, Chief Operating Officer & Board Member

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

MyoTherix Board Members (4)

Name Representing Role Since Contact
Info
John Kincaid MyoTherix Co-Founder, President & Board Member 000 0000
Mark De Souza Ph.D MyoTherix Co-Founder, Chief Operating Officer & Board Member 000 0000
Michael Kelly Ph.D MyoTherix Chief Executive Officer, Director & Co-Founder 000 0000

1 Former Board Member

You’re viewing 3 of 4 board members. Get the full list »